Randomized Clinical Trial to see effects of Yastimadhu Arka eye drop in managing the symptoms of Vataj Abhishyanda (simple allergic conjunctivitis) in comparison to Olopatadine 0.1% eye drop

Randomized Controlled Clinical Trial on Comparison of Yastimadhu Arka Eye Drop with Olopatadine 0.1% Eye Drop in Vataj Abhishyanda (Simple Allergic Conjunctivitis)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085610

Enrollment

Registered

2025-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms of pricking pain , lacrimation , friction of eyelids and signs like congestion and papillae of conjunctiva.

Exclusion criteria

Exclusion criteria: Patients suffering from any other ocular pathology like bacterial conjunctivitis , other types of allergic conjunctivitis , corneal opacity , dacryocystitis and tumors of eye .

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Yastimadhu Arka eye drop in reducing the symptoms of Vataja Abhishyanda(simple allergic conjunctivitis)Timepoint: The assessment of the patient will be done on day 1 , after which the intervention will be provided . Follow up will be taken after 3rd day and finally on 6th day .	—

Secondary

Measure	Time frame
Standardisation of Yastimadhu Arka eye drop .Timepoint: The Secondary outcome will be achieved in 6 weeks after CTRI registration is done .	—

Countries

India

Contacts

Public ContactDr Chirag Parmar

Dr D Y Patil College of Ayurved and Research Centre.

mayur.shiralkar@gmail.com9422007951

Outcome results